Abridge
4.4
Abridge turns clinical conversations into documentation and follow-up across the visit: pulling patient history beforehand, capturing the conversation in real time with support for decisions and orders, and producing finished notes, coding detail and patient summaries afterwards. It reports use across more than 300 health systems. Pricing is not published.
- Commercial use OK
- Enterprise contract
- Pricing
- Contact sales
- Free tier
- No
- Commercial use
- Permitted
- Japanese UI
- Not confirmed
- Enterprise contract
- Available
What it is good for
- Reducing clinician documentation burden
- Capturing coding detail at the point of care
- Health systems with revenue cycle pressure
- Nursing documentation as well as physician notes
Strengths and trade-offs
Strengths
- Covers before, during and after the visit rather than transcription alone
- Coding detail links documentation to revenue
- Substantial health system deployment base
Trade-offs
- No published pricing
- US healthcare workflows and coding standards
- Clinical deployment requires compliance review that takes months
Editors' review
Documentation burden is the clearest AI case in medicine
Clinicians spending hours on notes after seeing patients is a well-documented and expensive problem, and transcription plus structuring addresses it directly. The coding angle is what makes the business case rather than the time saving alone.
It is built around US coding and revenue cycle. The clinical value translates; the billing half does not.
Verdict
A clear case in US health systems. Evaluate the regulatory path before the product.
Compiled from official documentation and public sources, with our own editorial judgement. We do not publish figures we cannot source.